Biodexa Pharmaceuticals Plc
Develops treatments for rare diseases, diabetes, and cancer using proprietary drug delivery tech.
BDRX | NDAQ
Overview
Corporate Details
- ISIN(s):
- GB00BNGF1L75 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 1 CASPIAN POINT, CARDIFF
- Website:
- https://www.biodexapharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Biodexa Pharmaceuticals Plc is a clinical-stage biotechnology company that develops treatments for diseases with high unmet medical needs. The company leverages proprietary drug delivery technologies to improve the bioavailability and distribution of therapeutic agents. Its lead development program, eRapa™, is a proprietary oral formulation of rapamycin (sirolimus) being evaluated in a Phase 3 trial for familial adenomatous polyposis (FAP), a rare genetic disorder. The company's pipeline also includes Tolimidone, a potential first-in-class lyn kinase inhibitor for type 1 diabetes, and treatments for primary and metastatic brain cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Biodexa Pharmaceuticals Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biodexa Pharmaceuticals Plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biodexa Pharmaceuticals Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
